PL377325A1 - Podstawione benzodioksepiny - Google Patents
Podstawione benzodioksepinyInfo
- Publication number
- PL377325A1 PL377325A1 PL377325A PL37732503A PL377325A1 PL 377325 A1 PL377325 A1 PL 377325A1 PL 377325 A PL377325 A PL 377325A PL 37732503 A PL37732503 A PL 37732503A PL 377325 A1 PL377325 A1 PL 377325A1
- Authority
- PL
- Poland
- Prior art keywords
- benzodioxepins
- substituted
- substituted benzodioxepins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02028596 | 2002-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377325A1 true PL377325A1 (pl) | 2006-01-23 |
Family
ID=32668730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377325A PL377325A1 (pl) | 2002-12-20 | 2003-11-27 | Podstawione benzodioksepiny |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7253202B2 (pl) |
| EP (1) | EP1572685B1 (pl) |
| JP (1) | JP4575167B2 (pl) |
| KR (1) | KR20050084438A (pl) |
| CN (1) | CN1729187A (pl) |
| AR (1) | AR042554A1 (pl) |
| AT (1) | ATE350379T1 (pl) |
| AU (1) | AU2003289904B2 (pl) |
| BR (1) | BR0317342A (pl) |
| CA (1) | CA2511021C (pl) |
| DE (1) | DE50306228D1 (pl) |
| ES (1) | ES2280824T3 (pl) |
| MX (1) | MXPA05006433A (pl) |
| PL (1) | PL377325A1 (pl) |
| WO (1) | WO2004058746A1 (pl) |
| ZA (1) | ZA200505786B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7227023B2 (en) | 2003-04-30 | 2007-06-05 | Wyeth | Quinoline 3-amino chroman derivatives |
| CN106243088B (zh) | 2015-06-03 | 2019-01-04 | 广东东阳光药业有限公司 | 取代的哌嗪化合物及其使用方法和用途 |
| PL245768B1 (pl) * | 2022-12-01 | 2024-10-07 | Univ Medyczny W Lublinie | Pochodne N-((9-chloro-3,4-dihydro-2H-benzo[b][1,4]dioksepin-7-ylo)metylo)-2-(6-fluoro-1H-indol-3-ylo)etano-1-aminy, sposób ich wytwarzania i zastosowanie |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3700691A (en) * | 1969-06-09 | 1972-10-24 | Frosst & Co Charles E | 3,3-disubstituted-3,4-dihydrobenzodioxepins |
| US3812150A (en) * | 1969-06-09 | 1974-05-21 | Frosst & Co | 3,3-disubstituted-benzodioxepins |
| US3944560A (en) * | 1972-05-01 | 1976-03-16 | Merck & Co., Inc. | 3-Hydroxy-3-(1,2,5-thiadiazolyloxyalkanol)-3,4-dihydro-2H-1,5-benzodioxepin products |
| GB2007656B (en) * | 1977-11-05 | 1982-05-19 | Pfizer Ltd | Therapeutic agents |
| DK166779B1 (da) * | 1983-12-14 | 1993-07-12 | Takeda Chemical Industries Ltd | 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse |
| JP2865341B2 (ja) * | 1988-12-28 | 1999-03-08 | サントリー株式会社 | ベンゾオキサゼピン誘導体 |
| JP3732554B2 (ja) * | 1994-07-07 | 2006-01-05 | 旭化成ファーマ株式会社 | 新規な2,3−ジヒドロベンゾフラン誘導体、その製造方法および用途 |
| KR100186661B1 (ko) | 1994-07-07 | 1999-05-01 | 유미꾸라 레이이찌 | 신규 2,3-디히드로벤조푸란 유도체, 그의 제조 방법 및 용도 |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
-
2003
- 2003-11-27 MX MXPA05006433A patent/MXPA05006433A/es not_active Application Discontinuation
- 2003-11-27 JP JP2004562656A patent/JP4575167B2/ja not_active Expired - Fee Related
- 2003-11-27 AT AT03782241T patent/ATE350379T1/de not_active IP Right Cessation
- 2003-11-27 CN CNA200380106988XA patent/CN1729187A/zh active Pending
- 2003-11-27 PL PL377325A patent/PL377325A1/pl not_active Application Discontinuation
- 2003-11-27 BR BR0317342-9A patent/BR0317342A/pt not_active Application Discontinuation
- 2003-11-27 WO PCT/EP2003/013373 patent/WO2004058746A1/de not_active Ceased
- 2003-11-27 DE DE50306228T patent/DE50306228D1/de not_active Expired - Lifetime
- 2003-11-27 EP EP03782241A patent/EP1572685B1/de not_active Expired - Lifetime
- 2003-11-27 AU AU2003289904A patent/AU2003289904B2/en not_active Ceased
- 2003-11-27 KR KR1020057011542A patent/KR20050084438A/ko not_active Withdrawn
- 2003-11-27 ES ES03782241T patent/ES2280824T3/es not_active Expired - Lifetime
- 2003-11-27 CA CA2511021A patent/CA2511021C/en not_active Expired - Fee Related
- 2003-11-27 US US10/539,515 patent/US7253202B2/en not_active Expired - Fee Related
- 2003-12-19 AR ARP030104740A patent/AR042554A1/es unknown
-
2005
- 2005-07-19 ZA ZA200505786A patent/ZA200505786B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003289904A1 (en) | 2004-07-22 |
| CA2511021C (en) | 2012-08-21 |
| DE50306228D1 (de) | 2007-02-15 |
| JP2006512380A (ja) | 2006-04-13 |
| EP1572685A1 (de) | 2005-09-14 |
| AR042554A1 (es) | 2005-06-22 |
| EP1572685B1 (de) | 2007-01-03 |
| JP4575167B2 (ja) | 2010-11-04 |
| BR0317342A (pt) | 2005-11-08 |
| ZA200505786B (en) | 2006-04-26 |
| AU2003289904B2 (en) | 2009-12-10 |
| CA2511021A1 (en) | 2004-07-15 |
| WO2004058746A1 (de) | 2004-07-15 |
| KR20050084438A (ko) | 2005-08-26 |
| US20060167078A1 (en) | 2006-07-27 |
| ES2280824T3 (es) | 2007-09-16 |
| MXPA05006433A (es) | 2005-08-19 |
| US7253202B2 (en) | 2007-08-07 |
| ATE350379T1 (de) | 2007-01-15 |
| CN1729187A (zh) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50311874D1 (en) | Spirocyclische cyclohexan-derivate | |
| DE50312422D1 (en) | Aryloxime | |
| AU2003249738A8 (en) | Ostoscope | |
| AU2003297193A8 (en) | Meta-web | |
| IL163652A0 (en) | Substituted hydroxyethylamines | |
| DE50309217D1 (en) | Benzimidazolderivate | |
| AU2003252028A8 (en) | Heterodiamondoids | |
| AU2003279495A8 (en) | Alert-modeling | |
| DE50303619D1 (en) | Reibschweissvorrichtung | |
| DE50308027D1 (en) | Cyclohexyl-harnstoff-derivate | |
| DE50313444D1 (en) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
| DE50307787D1 (en) | Isophthalsäurederivate | |
| DE50311133D1 (en) | Carbonsäureamide | |
| DE50312412D1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative | |
| PL372307A1 (pl) | Podstawione 4-aminocykloheksanole | |
| AU2003264900A8 (en) | Cast-cutter | |
| DE50310169D1 (en) | Lingual-retainer | |
| DE50304964D1 (en) | Handhobelmaschine | |
| IL166740A0 (en) | Substituted heterocyclylpyrimidines | |
| AU2002367810A8 (en) | Bis-transition-metal-chelate-probes | |
| AU2003262681A8 (en) | Hemo-aide | |
| DE10392833D2 (en) | Geotextilie | |
| PL377325A1 (pl) | Podstawione benzodioksepiny | |
| AU2003253735A8 (en) | Vacuolins | |
| AU2002341221A8 (en) | Honey-brandy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |